Literature DB >> 16003500

Primary Central Nervous System Lymphoma (PCNSL) occurring in pregnancy.

D O'Mahony, A R A Razak, F Brett, L Grogan.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16003500     DOI: 10.1007/s00415-005-0822-z

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


× No keyword cloud information.
  11 in total

Review 1.  Lymphoma and pregnancy.

Authors:  B Pohlman; R M Macklis
Journal:  Semin Oncol       Date:  2000-12       Impact factor: 4.929

2.  Glucocorticoid-induced long-term remission in primary cerebral lymphoma: case report and review of the literature.

Authors:  B Pirotte; M Levivier; S Goldman; J M Brucher; J Brotchi; J Hildebrand
Journal:  J Neurooncol       Date:  1997-03       Impact factor: 4.130

3.  Combination chemotherapy and radiotherapy for primary central nervous system lymphoma: Radiation Therapy Oncology Group Study 93-10.

Authors:  Lisa M DeAngelis; Wendy Seiferheld; S Clifford Schold; Barbara Fisher; Christopher J Schultz
Journal:  J Clin Oncol       Date:  2002-12-15       Impact factor: 44.544

4.  Cognitive outcomes and long-term follow-up results after enhanced chemotherapy delivery for primary central nervous system lymphoma.

Authors:  L D McAllister; N D Doolittle; P E Guastadisegni; D F Kraemer; C A Lacy; J R Crossen; E A Neuwelt
Journal:  Neurosurgery       Date:  2000-01       Impact factor: 4.654

Review 5.  Cancer in pregnancy: maternal and fetal implications.

Authors:  B Weisz; E Schiff; M Lishner
Journal:  Hum Reprod Update       Date:  2001 Jul-Aug       Impact factor: 15.610

Review 6.  Management of cancer during pregnancy.

Authors:  D C Doll; Q S Ringenberg; J W Yarbro
Journal:  Arch Intern Med       Date:  1988-09

7.  Long-term survival in primary CNS lymphoma.

Authors:  L E Abrey; L M DeAngelis; J Yahalom
Journal:  J Clin Oncol       Date:  1998-03       Impact factor: 44.544

Review 8.  Therapeutic management of primary central nervous system lymphoma: lessons from prospective trials.

Authors:  A J Ferreri; M Reni; E Villa
Journal:  Ann Oncol       Date:  2000-08       Impact factor: 32.976

9.  Methotrexate: distribution in cerebrospinal fluid after intravenous, ventricular and lumbar injections.

Authors:  W R Shapiro; D F Young; B M Mehta
Journal:  N Engl J Med       Date:  1975-07-24       Impact factor: 91.245

10.  Primary CNS lymphoma: combined treatment with chemotherapy and radiotherapy.

Authors:  L M DeAngelis; J Yahalom; M H Heinemann; C Cirrincione; H T Thaler; G Krol
Journal:  Neurology       Date:  1990-01       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.